The Effect of Patient Empowerment Learning (With AI) About Itching in Hemodylasis Patients.

NCT07740083 | Active Not Recruiting

• 1 other identifier: MT2423257898MT465678MA45561978
• Study Type: interventional
• Target: 128
• Locations: 1 country
• Sites: 1

Brief Summary

This study investigates whether artificial intelligence-supported patient education can reduce itching and improve patient empowerment in individuals with chronic kidney disease undergoing hemodialysis.

Conditions

Kidney Disease; Chronc Kidney Disease Stage 5; Chronic Kidney Disease

Keywords

Artificial Intelligence; CKD; Patient Empowerment

Outcome Measures

Primary Outcomes (1)

• 5-D Itching Scale Score

  Changes in 5-D Itching Scale Score

  2 weeks

Secondary Outcomes (1)

• Patient Empowerment Scale Score

  2 weeks

Study Arms (2)

AI-Supported Patient Education Group

EXPERIMENTAL

The group who recieve the education

Behavioral: Artificial Intelligence-Supported Patient Education

Control Group

NO INTERVENTION

The group of who doesnt recieve the education

Interventions

Artificial Intelligence-Supported Patient Education BEHAVIORAL

The intervention consisted of an artificial intelligence-supported patient education program developed for patients with chronic kidney disease undergoing hemodialysis. The education focused on pruritus management and included information about the causes of itching, factors affecting pruritus, skin care, dietary recommendations, symptom management strategies, and self-management behaviors. The educational content was provided through an AI-supported website designed to improve patient empowerment and increase patients' knowledge and participation in their own care.

AI-Supported Patient Education Group

Eligibility Criteria

• Age: 18 Weeks - 65 Weeks
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Patients with CKD. Patients who have ithing symptom. Patients who is older than 18. Patients who takes hemodylasis treatment regularly and in order.

You may not qualify if:

• Patients who got dementia and alzheimers.
• Patients who is older than 65.
• Patients who doesnt want to join the study.

Sponsors & Collaborators

• Izmir Tinaztepe University: lead

Study Sites (1)

Nursing

Izmir, Ege, 35400, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Kidney Diseases; Renal Insufficiency, Chronic; Patient Participation

Condition Hierarchy (Ancestors)

Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Renal Insufficiency; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Patient Acceptance of Health Care; Treatment Adherence and Compliance; Health Behavior; Behavior

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: research assistant

Model Details: We use 5-D Itching Scale and Patient Empowerment Scale for the datas we collect from the patients. Our aim is see the effect of artificial intelligence-supported patient education in CKD patients who take hemodylasis.

Study Record Dates

• First Submitted: July 28, 2026
• First Posted: July 31, 2026
• Study Start: January 12, 2025
• Primary Completion: April 28, 2026
• Study Completion (Estimated): August 28, 2026
• Last Updated: July 31, 2026

Record last verified: 2026-07

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)